Advertisement Press Releases Archive - Page 174 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • What Chambers & Partners say about Carpmaels & Ransford

    This London-based firm offers a full service to clients such as Johnson & Johnson, Micron Technology and Nissan. It is particularly well known for its patent expertise in the life sciences field, defending Novartis' patents for meningitis vaccines and Gilvec, a treatment for chronic myelogenous leukaemia. "Carpmaels & Ransford is very adaptable and always on the ball, providing commercial, strategic advice and acting as an excellent sounding board for new ideas," say sources.

  • New Tool for Routines Polymer Analysis: Multi-Shot EGA/PY-3030D/S Pyrolyzer

    Shimadzu, one of the worldwide leading manufacturers in analytical instrumentation and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu’s GCMS-QP2010 quadrupole series and Frontier Lab’s new Multi-Shot EGA/PY-3030D(S) vertical micro furnace pyrolyzer. Both companies have teamed up in Pyrolysis-GCMS for years.

  • SHL to Speak and Exhibit at the World Drug Delivery Congress 2011

    With the increasing number of biologics coming to market, the demand for drug delivery solutions such as auto injectors has increased significantly in recent years. This demand is projected to grow even more rapidly in the next five years. While North America and Europe have been key drivers for such devices, the trend of launching more combination products has already begun to influence other regions such as Asia. As a result, events such as The World Drug Delivery Congress 2011 in Singapore will attract the attention of biopharmaceutical companies, drug delivery device manufacturers and more

  • Indiana CTSI Partners with GVK Biosciences to Provide National Access to Biomarkers Database

    In an agreement facilitated by the Indiana Economic Development Corporation (IEDC) during a February economic mission to India, the Indiana Clinical and Translational Sciences Institute (CTSI) has partnered with GVK Biosciences, Asia’s leading contract research organisation, to provide researchers across the United States access to GVK BIO’s Clinical Biomarker Database that will advance research on wide range of diseases.